ATE267583T1 - Arzneizubereitungen zur behandlung sexueller funktionsstörungen - Google Patents

Arzneizubereitungen zur behandlung sexueller funktionsstörungen

Info

Publication number
ATE267583T1
ATE267583T1 AT98912079T AT98912079T ATE267583T1 AT E267583 T1 ATE267583 T1 AT E267583T1 AT 98912079 T AT98912079 T AT 98912079T AT 98912079 T AT98912079 T AT 98912079T AT E267583 T1 ATE267583 T1 AT E267583T1
Authority
AT
Austria
Prior art keywords
treatment
medicinal preparations
functional disorders
sexual functional
sexual
Prior art date
Application number
AT98912079T
Other languages
English (en)
Inventor
Alan Drizen
Peter Rothbart
Gary M Nath
Original Assignee
Lam Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lam Pharmaceutical Corp filed Critical Lam Pharmaceutical Corp
Application granted granted Critical
Publication of ATE267583T1 publication Critical patent/ATE267583T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
AT98912079T 1997-03-28 1998-03-27 Arzneizubereitungen zur behandlung sexueller funktionsstörungen ATE267583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/825,121 US5952006A (en) 1995-09-29 1997-03-28 Drug preparations for treating impotency
PCT/US1998/006020 WO1998043614A1 (en) 1997-03-28 1998-03-27 Drug preparations for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
ATE267583T1 true ATE267583T1 (de) 2004-06-15

Family

ID=25243165

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912079T ATE267583T1 (de) 1997-03-28 1998-03-27 Arzneizubereitungen zur behandlung sexueller funktionsstörungen

Country Status (11)

Country Link
US (1) US5952006A (de)
EP (1) EP0971694B1 (de)
JP (1) JP2002513410A (de)
AT (1) ATE267583T1 (de)
AU (1) AU750321B2 (de)
CA (1) CA2285181A1 (de)
DE (1) DE69824164T2 (de)
ES (1) ES2222581T3 (de)
IL (1) IL132115A0 (de)
PT (1) PT971694E (de)
WO (1) WO1998043614A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251436B1 (en) * 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
ATE363292T1 (de) * 1998-09-04 2007-06-15 Scios Inc Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren
WO2000059491A2 (en) * 1999-04-06 2000-10-12 Zonagen, Inc. Methods for modulating the human sexual response
WO2001008659A1 (en) * 1999-07-30 2001-02-08 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
BRPI0406987A (pt) * 2003-01-31 2006-01-10 Sankyo Co Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral
CN1777429A (zh) 2003-04-02 2006-05-24 尼克美制药控股有限公司 前列腺素组合物和其治疗血管痉挛的应用
ATE536889T1 (de) * 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
FR2877574A1 (fr) * 2004-11-08 2006-05-12 Marie Claude Benattar Utilisation d'acide hyaluronique, eventuellement en association avec au moins un androgene pour le traitement de troubles sexuels ou urinaires feminins par amplification du point g et compositions.
US8703198B2 (en) 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
US20060293236A1 (en) * 2005-06-23 2006-12-28 Prescott Albert G Injectable Osteogenic Formula and Method of Using Same
BRPI0612674B8 (pt) * 2005-06-27 2021-05-25 Daiichi Sankyo Co Ltd preparação farmacêutica, uso de um antagonista do receptor de angiotensina ii e um bloqueador do canal de cálcio
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
GB0722507D0 (en) 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
RU2633236C2 (ru) 2011-04-07 2017-10-11 Нексмед Холдингс, Инк. Способы и композиции для лечения болезни рейно
CA2896038C (en) * 2015-07-03 2022-08-09 Glycobiosciences Inc. Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
EP0266968A3 (de) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelierte Salbe mit einem Vasodilator
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5527893A (en) * 1987-09-18 1996-06-18 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
CH679670A5 (en) * 1990-10-01 1992-03-31 Applied Pharma Res Commercial carrageenan purificn. - by treatment with hydrogen peroxide in hydrated, inert organic solvent
EP0516026A1 (de) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel und Verfahren zu seiner Herstellung
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
CA2123312A1 (en) * 1991-12-23 1993-07-08 Pharmacia & Upjohn Company A potent drug for treatment of erectile dysfunction
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GR1002418B (el) * 1992-07-29 1996-08-21 Johnson & Johnson Consumer Products Inc. Βιοεπισυναπτομενες συνθεσεις θεραπειας και μεθοδοι χρησης.
EP0859597B1 (de) * 1995-09-29 2003-04-09 LAM Pharmaceutical Corporation Verabreichungssystem mit verzoegerter freisetzung sowie langwirkende narkotische analgetika und antagonisten

Also Published As

Publication number Publication date
IL132115A0 (en) 2001-03-19
AU6588198A (en) 1998-10-22
EP0971694B1 (de) 2004-05-26
ES2222581T3 (es) 2005-02-01
DE69824164T2 (de) 2005-07-07
WO1998043614A1 (en) 1998-10-08
DE69824164D1 (de) 2004-07-01
AU750321B2 (en) 2002-07-18
PT971694E (pt) 2004-10-29
EP0971694A1 (de) 2000-01-19
CA2285181A1 (en) 1998-10-08
JP2002513410A (ja) 2002-05-08
US5952006A (en) 1999-09-14

Similar Documents

Publication Publication Date Title
ATE267583T1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
BR9812134A (pt) Composição farmacêutica para tratamento de dismenorréia e parto prematuro
GEP20043171B (en) Skin with a Minimal Systemic Effect
DE69613840T2 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
NO984446L (no) FremgangsmÕte for behandling av smerte
WO1996001100A3 (de) Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
RU94024337A (ru) Антиметастатическое средство
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
DE60122781D1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
NO991047L (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns
GEU2000587Y (en) Medicinal Ointment Turmanidze-Burduli Derma
RU94035330A (ru) Способ лечения кожных заболеваний
RU95108741A (ru) Способ рефлексотерапии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties